
Andrew Schorr is once again in a clinical trial, this time for a new generation of blood-thinning drugs. Follow Andrew's experience on his blog.
Patient Power’s Andrew Schorr survived leukemia in-part because of the treatment he received while participating in a phase II clinical trial. He received a now-FDA-approved combination treatment ten years before it was approved. Clinical trials may not be the right answer for you, but they are an important consideration, especially when facing an incurable or life-altering condition. You may have the opportunity to receive “tomorrow’s medicine today” and by participating you can help advance knowledge about your condition, all while receiving close monitoring and the best care available.
Many of our programs include questions and discussions on clincial trials specific to individual health concerns. Just launch the program in your health topic of interest and click the chapter on clinical trials!
Including conversation regarding clinical trials
|
Clinical Trials for PKU
|
|
|
|